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Edited by Hans-Dieter KlenkAbstract As an example of the cost-eﬀective large-scale
generation of small-interfering RNA (siRNAs), we have created
transgenic tobacco plants that produce siRNAs targeted to the
mRNA of the non-structural protein NS1 from the inﬂuenza A
virus subtype H1N1. We have investigated if these siRNAs,
speciﬁcally targeted to the 50-portion of the NS1 transcripts
(5mNS1), would suppress viral propagation in mammalian cells.
Agroinﬁltration of transgenic tobacco with an Agrobacterium
strain harboring a 5mNS1-expressing binary vector caused a
reduction in 5mNS1 transcripts in the siRNA-accumulating
transgenic plants. Further, H1N1 infection of siRNA-transfected
mammalian cells resulted in signiﬁcant suppression of viral
replication. These results demonstrate that plant-derived siRNAs
can inhibit viral propagation through RNA interference and
could potentially be applied in control of viral-borne diseases.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Mammalian cells; Anti-viral1. Introduction
RNA interference (RNAi) is an ancient and evolutionarily
conserved activity in eukaryotes. It results in RNA-mediated
RNA degradation in a sequence-speciﬁc manner. Originally
described in plants as a concerted inactivation of host genes
and transgenes transcribing the same or similar sequences [1],
it has been conﬁrmed to occur in many diﬀerent organisms.
Examples include quelling in Neurospora crassa [2], and RNAi
in Caenorhabditis elegans [3], Drosophila [4] and mammals [5].
In all these cases, RNAi is achieved through several closely
coordinated steps: (1) an endonuclease Dicer with RNase III
activity cleaves the dsRNA into 21–23 bp small interfering* Corresponding author. Fax: +852-28583477.
E-mail address: seanzhou@hkucc.hku.hk (Y. Zhou).
1 Present address: Biotech Center, Rutgers University, 59 Dudley
Road, New Brunswick, NJ 08901-8520, USA.
Abbreviations: NS1, gene encoding the non-structural protein NS1;
MDCK, Madin–Darby canine kidney; siRNA, small-interfering RNA;
RNAi, RNA interference; PTGS, post-transcriptional gene silencing;
EYFP, gene encoding the enhanced yellow ﬂuorescent protein
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doi:10.1016/j.febslet.2004.10.027RNAs (siRNAs); (2) the siRNAs interact with a multicom-
ponent nuclease to form an RNA-induced silencing complex
(RISC); (3) the siRNA in the RISC directs the complex to the
target RNA through sequence complementarity; (4) RNA
polymerization begins from the siRNA to form dsRNA; and
(5) the dsRNA is cleaved into siRNAs [6,7]. The resulting
siRNAs would then initiate another round of RNA cleavage.
Studies using synthetic [8], in vitro transcribed [9,10] and in
vivo transcribed [11,12] siRNAs, as well as viral-mediated
siRNA delivery [13], have demonstrated that well-designed
siRNAs can eﬀectively suppress target gene expression. Hence,
RNAi technology could eventually be applied in the thera-
peutics of human and animal viral diseases of which the mo-
lecular components, e.g., viral sequences, are known, and in
the case of infectious diseases, of which the relevant pathogens
have been identiﬁed. In plants, viral-resistance has already
been achieved through a plant RNAi pathway termed post-
trancriptional gene silencing (PTGS) [14].
Although some understanding on siRNA inhibition of viral
propagation [8,11] has been achieved, the local folding of the
target RNAs that reduces siRNA accessibility within a tran-
script [15] makes it necessary to test out many diﬀerent
siRNAs before optimal transcript degradation can be attained
[8,16]. For example [8], 20 siRNA oligos were screened before
identiﬁcation of one that could satisfactorily suppress repli-
cation of the inﬂuenza virus in mammalian cells. Also, siRNA-
mediated gene suppression in mammals requires the dsRNA to
be smaller than 30 bp to ensure speciﬁcity [17], as long dsRNA
can provoke non-speciﬁc degradation of RNA transcripts and
a general shutdown of protein translation [18]. Therefore, it is
impossible to transfect mammalian cells with long-dsRNA-
producing constructs essential for making multiple siRNAs.
The high cost in RNA oligo synthesis and the toxic eﬀects of
long dsRNA in mammalian cells could be ameliorated by cost-
eﬀective techniques in simultaneous large-quantity production
of diﬀerent siRNAs to achieve a satisfactory level for RNAi-
mediated gene suppression.
Here, we demonstrate that tobacco (Nicotiana tabacum) can
be engineered by Agrobacterium-mediated transformation to
produce siRNAs targeting the mRNA for the non-structural
NS1 protein of the inﬂuenza virus A/WSN/33, subtype H1N1.
The transgenic plants could eﬀectively accumulate siRNAs
that speciﬁcally target NS1 transcripts. Transfection of mam-
malian cells with plant-derived siRNAs followed by infection
of the inﬂuenza virus revealed signiﬁcant reduction in viral
propagation. Our data demonstrate that plants can be used asation of European Biochemical Societies.
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tion of diversiﬁed siRNAs.2. Materials and methods
2.1. Construction of hairpin RNA vector and generation of transgenic
tobacco plants
A 0.4-kb fragment representing the 50-portion of the NS1 mRNA
(5mNS1) from the inﬂuenza virus strain A/WSN/33 subtype H1N1
(Fig. 1A and B) was ampliﬁed by reverse-transcriptase polymerase
chain reaction (RT-PCR) using forward primer 50-gggcggccgc-
ggatccatggacccaaacactgtg-30 with NotI (in italics) and BamHI (in bold)
sites incorporated at its 50-end, and reverse primer 50-caac-
tagtatttcgctttcagtatga-30 with an added SpeI site (in italics). The un-
derlined nucleotides represent NS1 sequences. The PCR product was
initially cloned in pGEM-T Easy vector (Promega) for veriﬁcation of
DNA sequence. Subsequently, the pGEM-T Easy derivative was di-
gested with either BamHI and SpeI or NotI and SpeI. The 0.4-kb
BamHI–SpeI 5mNS1 fragment was cloned into corresponding sites in a
pBluescript SKII()) derivative that contains the Arabidopsis TGA1
intron [19] inserted at its SpeI–XbaI site. Next, the 0.4-kb NotI–SpeI
5mNS1 fragment from the pGEM-T Easy derivative was cloned in the
NotI–XbaI site of the pBluescript SK(II)()) derivative containing the
DNA fusion of ‘‘sense 5mNS1-TGA1 intron’’, to generate a dsRNA
cassette ‘‘sense 5mNS1-TGA1 intron–antisense 5mNS1’’. This cassette
was then released by NotI and BamHI digestion, and, with the help of
a NotI/XbaI adaptor (upper strand, 50-GGCCGAGTTGTTA-30; lower
strand, 50-CTAGTAACAACTC-30), was cloned in the BamHI–XbaI
site between the CaMV 35S promoter and the nos terminator, in an-
other pBluescript SKII()) derivative. The resulting vector therefore
contains a cassette of ‘‘35S-s 5mNS1–TGA1 intron–as 5mNS1-nos’’
(Fig. 1C). This cassette was further digested with NotI and KpnI, and
was cloned into corresponding sites within the T-DNA in a pBI101
backbone plasmid derivative (Clontech, Palo Alto, USA). The binary
vector was then mobilized into Agrobacterium tumefaciens strain
GV3101/MP90 for transformation of tobacco cultivar Samsun NN by
the leaf-disk procedure [20].2.2. siRNA detection
Total RNA samples were extracted from tobacco leaves using
TRIzol (Invitrogen). Twenty micrograms of total RNA was separated
on a 15% polyacrylamide gel containing 7 M urea and was electro-
blotted onto a nitrocellulose membrane (GeneScreen Plus, Perkin-
Elmer Life Sciences, Inc.). The blot was then hybridized overnight at
42 C to [32P]UTP-labeled 5mNS1 riboprobes generated using theATG
ATG 400 n
5mNS1 (400 nt)
Cap
CaMV 35S I - TGA1s- 5mNS1 as- 5
A
B
C
NS1 mRNA (8
Fig. 1. The 5mNS1 sequence and the hairpin RNA construct used in produ
mRNA. The cap and poly(A) tail structures are shown, and location of the 0.
(B) cDNA sequence of the 5mNS, with the sequence of the synthetic siRNA
cassette in a binary vector. The sense (S) and antisense (AS) 5mNS1 fragments
the control of the CaMV 35S promoter.Riboprobe in vitro Transcription Systems (Promega), in a solution of
50% (v/v) formamide, 250 mM NaCl, 7% SDS and 125 mM phosphate
buﬀer, pH 7.0. After hybridization, the blot was washed twice with 2·
SSC plus 0.5% SDS and was then analyzed using a phospho-imager.
The volumes of the synthetic siRNA and of the siRNA from transgenic
plants were measured using an ImageQuant software (Molecular Dy-
namics), and the amount of siRNA in the plant RNA sample was
calculated based on its volume relative to that of synthetic, known
amount of RNA oligos.2.3. Transient expression assay by agroinﬁltration
Agrobacterium cells containing the 5mNS1-expressing binary vector
and those containing an EYFP-T2m (EYFP, gene encoding the en-
hanced yellow ﬂuorescent protein) expressing binary vector [21] were
inoculated in an induction solution containing 1 g/l NH4Cl, 0.3 g/l
MgSO4.7H2O, 0.15 g/l KCl, 0.01 g/l CaCl2, 0.0025 g/l FeSO4 Æ 7H2O, 2
mM phosphate, 1% glucose, 20 mM 2-(N-morpholino)ethanesulfonic
acid (MES, pH 5.5), 100 lM acetosyringone, 50 lg/ml kanamycin and
50 lg/ml gentamycin. The EYFP-T2m contains EYFP fused in-frame
to a mutant version of the Arabidopsis TGA2 gene (T2m) and is used as
an expression reference after agroinﬁltration. Following overnight
culture at 28 C, the cells were collected by centrifugation at 3000 g
for 15 min, and then resuspended in an inﬁltration solution containing
10 mM MES (pH 5.5), 10 mM MgSO4 and 100 lM acetosyringone.
The resuspended Agrobacterium cells were adjusted to an OD600 of 0.8
with the same solution before inﬁltration of tobacco leaves using a 1 ml
syringe. After two days, total RNA was extracted from the inﬁltrated
leaf areas for Northern blot analysis.2.4. Northern blot analysis
Five micrograms of total RNA, extracted from the agroinﬁltrated
and non-inﬁltrated leaf areas, were separated on a 1.2% agarose gel,
blotted with 20 SSC onto a nitrocellulose membrane, and hybridized
to [32P]dCTP-labeled DNA probes generated from 5mNS1 and EYFP
DNA fragments using a Rediprime II Random Prime Labelling
System (Amersham, UK). Hybridization was performed at 65 C
overnight in a buﬀer containing 250 mM NaCl, 7% SDS and 125 mM
phosphate, pH 7.0. After hybridization, the blot was washed twice at
room temperature in 2 SSC plus 0.5% SDS, then at 65 C for 15 min
in 0.2 SSC plus 0.1% SDS. The blot was analyzed using a phospho-
imager.
2.5. Transfection of mammalian cells followed by infection with
inﬂuenza virus
Conﬂuent Madin–Darby canine kidney (MDCK) cells grown in a T-
175 ﬂask were washed twice with phosphate-buﬀered saline (PBS) and
trypsinized for 10 min in 10 ml trypsin solution at 37 C. After ter-A(n) 890 nt
t
TnosmNS1
90 nt)
cing 5mNS1 siRNAs in tobacco. (A) Schematic representation of NS1
4-kb 5mNS1 fragment beginning from the ﬁrst codon (atg) is indicated.
NS-128 used by Ge et al. [8] underlined. (C) Diagram showing RNAi
are separated by the Arabidopsis TGA1 intron (I-TGA1), and are under
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centrifugation for 5 min at 15,000 rpm, and were washed twice in 30 ml
cold PBS, followed by one wash in 30 ml cold RPMI1640 medium
(Gibco), before resuspension in cold RPMI1640 to a density of 1 107
cells/ml. Subsequently, 500 ll of resuspended cells was transferred into
a 0.4 cm pre-chilled cuvette, and was mixed with 10 ll water, 10 ll
water with 42 ng NS-128, 10 ll wild-type RNA sample or 10 ll RNA
sample containing 42 ng siRNAs from transgenic plant. Equal
amounts of total RNA from wild-type or transgenic plants were used.
The cuvette was kept on ice for 10 min, before electroporation at 0.4
kV and 960 lF using a gene pulser system (Bio-Rad). Cells were then
transferred into 5.6 ml of pre-warmed MDCK medium (MEM, 10%
cow serum, 1% penicillin and 1% streptomycin). Three milliliters was
transferred into a 6-well plate and incubated at 37 C for 24 h before
infection with the inﬂuenza virus.Fig. 2. Accumulation of the 5mNS1 siRNA in selected primary
transformants and in wild-type tobacco (WT). (A) Twenty micrograms
of total RNA from leaves of transgenic tobacco was separated on a
15% polyacrylamide gel containing 7 M urea, blotted and hybridized
to [32P]UTP-labeled 5mNS1 riboprobes. (B) Normalization of RNA
loading was based on the separation of 6 lg of total RNA on a 1.2%
agarose gel.2.6. Virus infection and hemagglutination (HA) titer test
Twenty-four hours after transfection, cells in each well were washed
twice with PBS, and 300 ll diluted inﬂuenza virus strain A/WSN/33
(MOI¼ 0.001 in PBS) was added into the well. After shaking the
mixture for 1 h, the viruses in the supernatant were discarded, and 2 ml
infection medium [0.5 lg/ml TPCK-trypsin (Sigma), 0.5% FCS (Gib-
co), and 1% PS with MEM (Gibco)] was added into the well. The cells
were then incubated at 37 C. Supernatants were collected at diﬀerent
post-infection time points for the HA titer test as described [8].3. Results and discussion
Inﬂuenza A viruses are medically important viral pathogens
that cause signiﬁcant mortality and morbidity throughout the
world. Their easy transmission, antigenic shift and drift have
made current methodology of vaccination and therapy limited
in eﬃcacy [22]. Inhibitors of the anti-M2 ion channel and
neuraminidase are common drugs for inﬂuenza, but both have
their drawbacks. The anti-M2 ion channel inhibitors (e.g.,
amantidine) induce viruses to develop drug-resistant muta-
tions, while the neuraminidase inhibitors (e.g., Tamiﬂu),
though very potent, are eﬀective only at early disease onset. To
investigate if plant-derived siRNAs against the inﬂuenza virus
could inhibit viral replication, we selected a 0.4-kb fragment
representing the 50-portion of the NS1 gene in strain A/WSN/
33, subtype H1N1. The NS virion RNA (vRNA) consists of
about 890 nucleotides and encodes two non-structural pro-
teins, NS1 and NS2. The sequence of this vRNA is highly
conserved among diﬀerent subtypes of inﬂuenza viruses [23].
The NS1 protein has not only been proposed to regulate viral
replication cycle, splicing and translation of mRNAs [24], but
also been shown to have inhibitory eﬀect on cellular mRNA
maturation and cellular anti-viral response [25]. Thus, the NS1
gene plays an important role in virus replication and virus–
host interactions. The chosen 0.4-kb fragment was ampliﬁed
by PCR, and then sequentially cloned in sense and antisense
orientations, on either side of the Arabidopsis TGA1 intron.
The resulting cassette of ‘‘sense–intron–antisense’’ was ex-
pressed from the CaMV 35S promoter in a binary vector
(Fig. 1C). Hence, transgenic plants obtained in Agrobacterium-
mediated plant transformation from this binary vector should
produce hairpin dsRNA, which would subsequently be pro-
cessed into siRNAs by the PTGS machinery.
Reports have shown that ‘‘sense–antisense’’ cassettes can be
transcribed to produce siRNAs after transfection of host cells
[11,26,27]. To investigate if the construct generated in this
study (Fig. 1C) could produce siRNA in transgenic tobacco,
RNAs from leaves of primary transformants was separated on
a gel of 15% polyacrylamide and 7 M urea, blotted onto ni-trocellulose membrane and hybridized to [32P]UTP-labeled
5mNS1 riboprobes. Of 21 independent transformants
screened, 13 showed obvious siRNA production. The levels of
siRNA accumulation in diﬀerent lines varied, some produced
obvious signals after an overnight exposure using a phospho-
imager, while others barely yielded visible signals (data not
shown). The siRNA signals in selected transgenic lines are
shown in Fig. 2. Transgenic lines 1 and 2 had apparent accu-
mulation of 5mNS1 siRNAs, while lines 8 and 9 produced
much lower levels of the same siRNAs. In line 10, the siRNAs
were barely detectable.
A variation in siRNA levels may be due to several reasons.
First, T-DNA location in the genome could aﬀect expression.
In Agrobacterium-mediated plant transformation, T-DNA is
transferred from the bacterium to the eukaryotic host cell and
further integrated into the host genome [28]. If the transgene
were inserted in the genome where active transcription occurs,
the transgene would be active. Otherwise, it would be less
active or even silent. Second, the copy number of the transgene
may be a contributing factor in expression levels, although in
some cases, transgene activity may not be directly proportional
to its copy number due to co-suppression. Third, methylation
of transgene may occur, especially at or near promoter if it is
considered foreign. As a safeguard, the host generally has a
mechanism to methylate and inactivate the transgene. This has
been reported with foreign DNA expressing dsRNA in PTGS
[29,30] and is supported by a requirement of DNA methylase
in initiating RNA-dependent DNA methylation [31].
As revealed by an increasing number of reports, siRNA is
the hallmark in triggering RNAi. Therefore, the accumulated
5mNS1 siRNAs in the transgenic plants should initiate deg-
radation of NS1 transcripts or endogenous tobacco transcripts
with sequences complementary to 5mNS1. A BLAST analysis
was performed with 5mNS1 as query sequence for such com-
plementation in transcripts of tobacco or species evolutionarily
close to tobacco, but no match was identiﬁed. Northern blot
analysis of tobacco total RNA with the 5mNS1 probe also did
not yield any obvious bands. Therefore, 5mNS1 does not seem
to share homology to any tobacco transcripts and would not
cause unintended degradation of RNA transcribed from en-
dogenous genes. This is consistent with the fact that no ab-
normal phenotypes were observed in all the transgenic lines
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were functional in degrading NS1 transcripts speciﬁcally,
5mNS1- and EYFP-T2m-expressing binary vectors were in-
troduced into Agrobacterium cells which were used to co-in-
ﬁltrate leaves of wild-type tobacco and those of transgenic
tobacco lines expressing 5mNS1 siRNAs. As shown in Fig. 3B,
all the three transgenic lines 1, 9 and 19, representing high,
middle and low accumulation of 5mNS1 siRNA, respectively,
had reduced 5mNS1 RNA levels, indicating that plant-derived
5mNS1 siRNAs indeed triggered PTGS of NS1 in vivo. A
negative correlation was observed between the levels of 5mNS1
siRNAs and 5mNS1 transcripts in inﬁltrated tobacco leaves.
To obtain a percentage of the 5mNS1 transcript level in theFig. 3. Suppression of 5mNS1 transcript accumulation in siRNA-expressing l
of 5mNS1 siRNAs were co-inﬁltrated with two binary vectors separately expre
samples were collected for RNA analysis by Northern blot analysis. (A) Par
showing levels of EYFP-T2m and 5mNS1 transcripts in the diﬀerent inﬁltra
5mNS1 levels are lowered in transgenic plants when compared to levels in WT
calculated with data from three separate inﬁltrations. Calculation was perfo
5mNS1 level ð% of WTÞ ¼ ð100Þ  ð5mNS1 volume of transgenic lineÞ  ðEYð5mNS1 volume of wild typeÞ  ðEYFP volumtransgenic lines relative to that of wild-type, volumes of each
5mNS1 band and of the reference EYFP band were determined
using the ImageQuant software, and percentage was calculated
using the formula described in Fig. 3 legend. In transgenic
tobacco line 1, which had the highest level of 5mNS1 siRNA
accumulation, the percentage was only 0.4%, demonstrating
high eﬃciency of this line in 5mNS1-speciﬁc RNA degradation
(Fig. 3C).
In RNAi studies, synthetic or in vitro expressed siRNAs
have been used in transfection of target cells [26], and injection
of worms [32] and animals [33], for evaluation of siRNA eﬃ-
cacy. To test if the 5mNS1 siRNAs produced in transgenic
tobacco could be potentially used in suppressing viral propa-ines. Wild-type tobacco and transgenic plants expressing diﬀerent levels
ssing 5mNS1 and a fusion fragment of EYFP T2m. After two days, leaf
t of the T-DNA in the two binary vectors. (B) Northern blot analysis
ted samples. The 28S rRNA was stained with ethidium bromide. The
. (C) The 5mNS1 transcript level, as a percentage of the wild-type, was
rmed according to the formula of:
FP volume of wild-typeÞ
e of transgenic lineÞ :
Fig. 4. Plant-derived 5mNS1 siRNAs can suppress replication of the inﬂuenza virus A/WSN/33 in mammalian cells. (A) Total RNA (10 lg) from
primary transformants 1 and 2 was separated on a 15% polyacrylamide gel, blotted onto a Nylon membrane and probed with [32P]UTP-labeled
5mNS1 RNA probes. Quantity of siRNAs in the RNA samples was calculated based on its relative volume to that of known amount of synthetic
siRNA oligo. These RNA preparations were then used for transfection of MDCK cells. (B) Normalization of RNA loading was based on the
separation of 6 lg of total RNA on a 1.2% agarose gel. (C) Suppression of viral replication as revealed in three independent HA titer assays. MDCK
cells were ﬁrst transfected with water (mock), a siRNA oligo NS-128 used by Ge et al. [8], and RNA from wild-type tobacco (control) or from two
transgenic lines (line 1 and line 2) expressing siRNAs, and were then infected by inﬂuenza virus strain A/WSN/33 24 h post-transfection. HA titer was
determined at 24 (blue boxes), 36 (red boxes) and 48 h (yellow boxes) post-infection.
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5mNS1 siRNAs were harvested from the leaves of transgenic
plants for transfection of MDCK cells. The amount of siRNA
in total RNA was quantiﬁed by siRNA analysis (Fig. 4A). As a
positive control, we used siRNA oligo NS-128 (50-
CGGCUUCGCCGAGAUCAGAdAdT-30), since it has been
proven best of three NS1-targeting siRNA oligos [8]. Cells
transfected with RNA from non-transformed plants were the
negative control and cells transfected with water constituted
the mock transfection. Twelve hours after transfection, cells
were infected by the inﬂuenza virus strain A/WSN/33
(MOI¼ 0.001). The HA titer, which is an indicator of viral
replication, was determined at 12, 24 and 36 h post-infection.
The mock-transfected and the negative control cells showed
similar HA titer, indicating that RNA from wild-type tobacco
plants did not suppress viral replication. Though the HA titer
values varied in three separate sets of transfection and infec-
tion studies, a phenomenon unavoidably associated with
conditions of the cells, e.g., passage history, both plant-derived
and synthetic siRNAs signiﬁcantly reduced H1N1 viral repli-
cation. The anti-viral eﬀect of siRNA was most prominent at
36 h post-infection (Fig. 4B). In one set of experiments, plant-
derived siRNA proved superior to the NS-128 oligo (Fig. 4B,
experiment A).
These results strongly support our hypothesis that 5mNS1
siRNA from transgenic plants can eﬀectively suppress repli-
cation of the inﬂuenza virus in mammalian cells. In addition,plant siRNAs showed similar suppression ability as the syn-
thetic siRNA NS-128, demonstrating that plant-derived
siRNAs confer the same eﬃcacy. Given the fact that transgenic
plants can generate siRNAs targeting diﬀerent areas of the
5mNS1 transcript, and that NS1 sequences are highly con-
served among inﬂuenza viruses [23], 5mNS1 siRNAs from
transgenic plants should suppress the replication of a broad
range of inﬂuenza viral subtypes with sequences homologous
to the 5mNS1.
While our results clearly indicate anti-viral eﬀects of plant-
derived 5mNS1 siRNAs, this study is primarily focusing on
developing a strategy for economical and sustainable produc-
tion of siRNAs. Besides using transgenic technology described
in this study, a pool of siRNAs can also be generated with
Dicer-dependent kits. When compared with the transgenic
approach, the latter method is much more expensive, since it
involves expensive reagents (i.e., dNTP, Dicer, and RNA
polymerase), complicated steps (i.e., in vitro transcription, in
vitro cleavage of dsRNA, and clean-up) and experienced re-
searcher. The high cost not only limits production scale, but
also requires repetition of the production process if the
siRNAs are to be used over and over again. Therefore, our
proof-of-concept study demonstrates that transgenic plants are
superior to the commercial kits for siRNA production and the
time taken for generating them would be well compensated.
Though the NS1-targeting siRNAs possess anti-viral eﬀects,
those against the NP genes would be more potent in sup-
350 Y. Zhou et al. / FEBS Letters 577 (2004) 345–350pressing viral replication, as revealed by studies using mam-
malian cells [8] and animals [34]. In both studies, one of the
NP-targeting siRNAs, NP-1496, signiﬁcantly reduced the virus
titers. These observations indicate that mRNA of the NP gene
might be a better target of siRNA, if positional eﬀects on
siRNA accessibility could be faithfully addressed. In our fu-
ture study of using transgenic plant-derived siRNAs for viral
suppression, generating NP-targeting siRNAs would be a
more practical practice.
In conclusion, 5mNS1 siRNAs capable of activating RNAi
in mammalian cells against NS1 were produced in transgenic
tobacco plants. The eﬃcacy of the plant-derived siRNAs was
tested in vivo by agroinﬁltration of the 5mNS1-expressing
construct in leaves of transgenic tobacco and in vitro by ap-
plication of these siRNAs in mammalian cells to inhibit in-
ﬂuenza viral replication. This cost-eﬀective technique in
utilizing transgenic plants for large-scale siRNA production
could have advantages over current methods involving the use
of synthetic RNA oligos, the expression of short hairpin RNA
in Escherichia coli [35,36] and the transfection of mammalian
cells with short dsRNA. In addition, plant cells can apparently
tolerate expression of long dsRNAs, enabling the length of the
target gene fragment to be easily manipulated for optimal
suppression. Moreover, fragments producing siRNAs target-
ing multiple sites of the viral genome can be fused together so
that one transgenic plant can produce siRNAs for simulta-
neous silencing of multiple genes. This could provide a more
robust and sustained viral protection minimizing the likeli-
hood of the virus developing resistance to the siRNA through
mutation of the target sequence.
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